Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stergios A Polyzos

Showing results (71-80 of 431) with videos related to

Pageof 44
Sort By:
European Journal of Pharmacology|June 20, 2021
Sodium-glucose co-transporter 2 inhibitors in nonalcoholic fatty liver diseaseEvangelia S Makri, Antonis Goulas, Stergios A Polyzos
Metabolism: Clinical and Experimental|June 21, 2021
Irisin in nonalcoholic fatty liver disease: Need for an updated meta-analysisStergios A Polyzos, Jannis Kountouras, Athanasios D Anastasilakis
Metabolism: Clinical and Experimental|March 27, 2019
Of mice and men: Why progress in the pharmacological management of obesity is slower than anticipated and what could be done about it?Chrysoula Boutari, Stergios A Polyzos, Christos S Mantzoros
Hormones (Athens, Greece)|July 18, 2012
Acute transient thyroid swelling following needle biopsy: an updateStergios A Polyzos, Athanasios D Anastasilakis, Georgios Arsos
Metabolism: Clinical and Experimental|May 10, 2019
Fatty liver in lipodystrophy: A review with a focus on therapeutic perspectives of adiponectin and/or leptin replacementStergios A Polyzos, Nikolaos Perakakis, Christos S Mantzoros
Annals of Hepatology|October 6, 2015
Nonalcoholic fatty liver disease and polycystic ovary syndromeStergios A Polyzos, Dimitrios G Goulis, Jannis Kountouras
Cancers|November 14, 2023
Tumor Necrosis Factor-Alpha and Adiponectin in Nonalcoholic Fatty Liver Disease-Associated Hepatocellular CarcinomaIlias D Vachliotis, Ioannis Valsamidis, Stergios A Polyzos
Expert Review of Endocrinology & Metabolism|February 10, 2019
Paget's disease of bone: emphasis on treatment with zoledronic acidStergios A Polyzos, Athanasios D Anastasilakis, Evangelos Terpos
Alimentary Pharmacology & Therapeutics|August 20, 2021
Review article: non-alcoholic fatty liver disease and cardiovascular diseases: associations and treatment considerationsStergios A Polyzos, Stergios Kechagias, Emmanuel A Tsochatzis
Metabolism: Clinical and Experimental|October 1, 2015
Irisin: A true, circulating hormoneStergios A Polyzos, Hannah Mathew, Christos S Mantzoros
Pageof 44

Showing results (71-80 of 431) with videos related to

Sort By:
Pageof 44
European Journal of Pharmacology|June 20, 2021
Sodium-glucose co-transporter 2 inhibitors in nonalcoholic fatty liver diseaseEvangelia S Makri, Antonis Goulas, Stergios A Polyzos
Metabolism: Clinical and Experimental|June 21, 2021
Irisin in nonalcoholic fatty liver disease: Need for an updated meta-analysisStergios A Polyzos, Jannis Kountouras, Athanasios D Anastasilakis
Metabolism: Clinical and Experimental|March 27, 2019
Of mice and men: Why progress in the pharmacological management of obesity is slower than anticipated and what could be done about it?Chrysoula Boutari, Stergios A Polyzos, Christos S Mantzoros
Hormones (Athens, Greece)|July 18, 2012
Acute transient thyroid swelling following needle biopsy: an updateStergios A Polyzos, Athanasios D Anastasilakis, Georgios Arsos
Metabolism: Clinical and Experimental|May 10, 2019
Fatty liver in lipodystrophy: A review with a focus on therapeutic perspectives of adiponectin and/or leptin replacementStergios A Polyzos, Nikolaos Perakakis, Christos S Mantzoros
Annals of Hepatology|October 6, 2015
Nonalcoholic fatty liver disease and polycystic ovary syndromeStergios A Polyzos, Dimitrios G Goulis, Jannis Kountouras
Cancers|November 14, 2023
Tumor Necrosis Factor-Alpha and Adiponectin in Nonalcoholic Fatty Liver Disease-Associated Hepatocellular CarcinomaIlias D Vachliotis, Ioannis Valsamidis, Stergios A Polyzos
Expert Review of Endocrinology & Metabolism|February 10, 2019
Paget's disease of bone: emphasis on treatment with zoledronic acidStergios A Polyzos, Athanasios D Anastasilakis, Evangelos Terpos
Alimentary Pharmacology & Therapeutics|August 20, 2021
Review article: non-alcoholic fatty liver disease and cardiovascular diseases: associations and treatment considerationsStergios A Polyzos, Stergios Kechagias, Emmanuel A Tsochatzis
Metabolism: Clinical and Experimental|October 1, 2015
Irisin: A true, circulating hormoneStergios A Polyzos, Hannah Mathew, Christos S Mantzoros
Pageof 44